Home
/
Treatment
/
cyclo(-y-aminobutyryl-L-phenylalanyl-L-tryptophanyl-D-tryptophanyl-L-lysyl-L-threonly-L-phenylalanyl-N-3-carboxypropyl)-glycine amide, acetate salt

cyclo(-y-aminobutyryl-L-phenylalanyl-L-tryptophanyl-D-tryptophanyl-L-lysyl-L-threonly-L-phenylalanyl-N-3-carboxypropyl)-glycine amide, acetate salt

	cyclo(-y-aminobutyryl-L-phenylalanyl-L-tryptophanyl-D-tryptophanyl-L-lysyl-L-threonly-L-phenylalanyl-N-3-carboxypropyl)-glycine amide, acetate salt
Trade Name
Orphan Indication	Acromegaly
USA Market Approval	USA
USA Designation Date	2013-06-24 00:00:00
Sponsor	Cortendo AB;900 Northbrook Drive;Trevose, Pennsylvania, 19053

Related Access Program

Novartis Pharmaceuticals – Acromegaly